2022 -- S 2870

========

LC005392

========

     STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2022

____________

S E N A T E   R E S O L U T I O N

PROCLAIMING MAY 1ST THROUGH MAY 8TH TO BE "TARDIVE DYSKINESIA (TD)

AWARENESS WEEK" IN THE STATE OF RHODE ISLAND

     Introduced By: Senator Joshua Miller

     Date Introduced: April 12, 2022

     Referred To: Recommended for Immediate Consideration

     WHEREAS, Many people with serious, chronic mental illness, such as schizophrenia,

bipolar disorder, severe depression, or gastrointestinal disorders, including gastroparesis, nausea,

and vomiting require treatment with medications that work as dopamine receptor blocking agents

(DRBAs), including antipsychotics; and

     WHEREAS, While ongoing treatment with these medications can be very helpful, and

even lifesaving, for many people, it can also lead to Tardive Dyskinesia (TD); and

     WHEREAS, Tardive Dyskinesia is a movement disorder that is characterized by random,

involuntary, and uncontrolled movements of different muscles in the face, trunk and extremities;

and

     WHEREAS, Tardive Dyskinesia can develop months, years, or decades after a person

starts taking DRBAs and even after they have discontinued use of those medications. Not

everyone who takes a DRBA develops TD, but if it develops it is often permanent; and

     WHEREAS, It is estimated that over 600,000 Americans suffer from Tardive Dyskinesia.

According to the National Alliance for Mental Illness, one in every four patients receiving long-

term treatment with an antipsychotic medication will experience Tardive Dyskinesia; and

     WHEREAS, Years of difficult and challenging research have resulted in recent scientific

breakthroughs, with two new treatments for Tardive Dyskinesia approved by the United States

Food and Drug Administration; and

     WHEREAS, Tardive Dyskinesia is often unrecognized and patients suffering from the

illness are commonly misdiagnosed. Regular screening for TD in patients taking DRBA

medications is recommended by the American Psychiatric Association (APA); now, therefore be

it

     RESOLVED, That this Senate of the State of Rhode Island hereby proclaims May 1st

through May 8th to be "Tardive Dyskinesia (TD) Awareness Week" in the State of Rhode Island;

and be it further

     RESOLVED, That this Senate hereby encourages the medical community and all

individuals in the United States and Rhode Island to become better informed about and aware of

Tardive Dyskinesia; and be it further

     RESOLVED, That the Secretary of State be and hereby is authorized and directed to

transmit a duly certified copy of this resolution to Ms. Karla M. Kiriako, Director, State

Government Affairs-East, Neurocrine Biosciences, Inc.

========

LC005392

========

LC005392 - Page 2 of 2